Search Within

Elisa De Stanchina

  1. "2021"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (14)
  3. Correspondence (1)
Groups
  1. Sloan Kettering Institute Postdocs (37)
  2. Department of Medicine (35)
  3. GSK Faculty (33)
  4. Solid Tumor Oncology Division (31)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (22)
  6. Human Oncology and Pathogenesis Program (22)

More Groups

People
  1. Charles Rudin (15)
  2. Triparna Sen (12)
  3. Andrew Chow (9)
  4. Fathema Uddin (9)
  5. Marissa Mattar (9)
  6. Nisargbhai Shah (9)

More People

Years
  1. 2021 (43)
Publications
  1. Cancer Research (6)
  2. Annals of Oncology (4)
  3. Cancer Discovery (3)
  4. Clinical Cancer Research (3)
  5. Journal of Clinical Oncology (3)
  6. Journal of Thoracic Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. Cell Press (5)
  3. Elsevier Inc. (4)
  4. Oxford University Press (4)
  5. American Society of Clinical Oncology (3)
  6. Nature Publishing Group (3)

More Publishers

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • LSD1 inhibition restores MHC class I expression and augments the anti-tumor response of immune checkpoint blockade in small cell lung cancer
    Meeting Abstract

    Sen, T.; Nguyen, M. N.; Taniguchi, H.; Chow, A.; De Stanchina, E.; Rudin, C. M.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer
    Journal Article

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    iScience (2021)

    Fulltext@MSK | Save
  • Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation
    Journal Article

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Meng, F.; Uddin, F.; Manoj, P.; Donoghue, M. T. A.; Won, H. H.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Journal Article

    Zhao, Y.; Murciano-Goroff, Y. R.; Xue, J. Y.; Ang, A.; Lucas, J.; Mai, T. T.; Da Cruz Paula, A. F.; Saiki, A. Y.; Mohn, D.; Achanta, P.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer
    Journal Article

    Joshi, S.; Gomes, E. D.; Wang, T.; Corben, A.; Taldone, T.; Gandu, S.; Xu, C.; Sharma, S.; Buddaseth, S.; Yan, P.; more...
    Communications Biology (2021)

    Fulltext@MSK | Save
  • Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y.; Hasan, M.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Chan, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • CRISPR screen reveals XPO1 as a therapeutic target strongly sensitizing to first and second line therapy in small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • EZH2 blockade overcomes suppression of the proinflammatory senescence-associated secretory phenotype in the pancreas and drives NK cell-mediated pancreatic tumor responses
    Meeting Abstract

    Chibaya, L.; Lopez-Diaz, Y.; Liu, H.; Murphy, K. C.; Morris, J. P. 4th; Ho, Y. J.; Simon, J.; Luan, W.; Kulick, A.; Leang, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis
    Journal Article

    Duan, S.; Moro, L.; Qu, R.; Simoneschi, D.; Cho, H.; Jiang, S.; Zhao, H.; Chang, Q.; de Stanchina, E.; Arbini, A. A.; more...
    Cell Reports (2021)

    Fulltext@MSK | Save
  • HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
    Journal Article

    Smith, A. E.; Ferraro, E.; Safonov, A.; Morales, C. B.; Lahuerta, E. J. A.; Li, Q.; Kulick, A.; Ross, D.; Solit, D. B.; de Stanchina, E.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save